Davis's Drug Guide
Beyaz
Phase I
drospirenone 3 mg + ethinyl estradiol 20 mcg + levomefolate 0.451 mg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Beyaz." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109775/all/Beyaz.
Vallerand AHA, Sanoski CAC, Quiring CC. Beyaz. Davis's Drug Guide. F.A. Davis Company; 2024. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109775/all/Beyaz. Accessed December 4, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Beyaz. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109775/all/Beyaz
Vallerand AHA, Sanoski CAC, Quiring CC. Beyaz [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 December 04]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109775/all/Beyaz.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beyaz
ID - 109775
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109775/all/Beyaz
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
